USPSTF Issues Recs on Using Breast Cancer Risk-Reducing Meds
The US Preventive Services Task Force has issued final recommendations on the use of medications for primary prevention of breast cancer.
All articles by Diana Ernst, RPh
FDA Rejects sNDA for Hetlioz in Jet Lag Disorder
The FDA has rejected the supplemental New Drug Application for Hetlioz (tasimelteon; Vanda Pharmaceuticals) for the treatment of jet lag disorder.
